India Glycols Demerged Entity EBPL Lists 2.23 Cr Shares

Key Event Details

Ennature Bio Pharma Limited received formal Listing and Trading Approvals from both BSE Limited and National Stock Exchange of India Limited on November 2, 2026. The approvals pertain to the equity shares issued and allotted pursuant to the Scheme of Arrangement among India Glycols Limited (Demerged Company), Ennature Bio Pharma Limited (Resulting Company 1), and IGL Spirits Limited (Resulting Company 2).

Quantitative Details

• Number of Shares Listed: 2,23,42,255 equity shares
• Face Value: Rs. 5/- per share
• Total Listed Capital: Approximately Rs. 11.17 crore (based on face value)
• Date of Approval: November 2, 2026
• Trading Commencement Date: November 4, 2026

Additional Information

The approval letters are available on the websites of both stock exchanges:

• BSE: https://www.bseindia.com/markets/marketinfo/noticescirculars?id=0
• NSE: https://www.nseindia.com/resources/exchange-communication-circulars